Search

Author/Creator Hebeisen, Simon

1. Applying the CiPA approach to evaluate cardiac proarrhythmia risk of some antimalarials used off‐label in the first wave of COVID‐19. Issue 3 (9th April 2021)

Authors:
Delaunois, Annie; Abernathy, Matthew; Anderson, Warren D.; Beattie, Kylie A.; Chaudhary, Khuram W.; Coulot, Julie; Gryshkova, Vitalina; Hebeisen, Simon; Holbrook, Mark; Kramer, James; Kuryshev, Yuri; Leishman, Derek; Lushbough, Isabel; Passini, Elisa; Redfern, Will S.; Rodriguez, Blanca; Rossman,...
Journal:
Clinical and translational science
Issue:
Volume 14:Issue 3(2021)
Page Start:
1133
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Eslicarbazepine and the enhancement of slow inactivation of voltage-gated sodium channels: A comparison with carbamazepine, oxcarbazepine and lacosamide. (February 2015)

Authors:
Hebeisen, Simon; Pires, Nuno; Loureiro, Ana I.; Bonifácio, Maria João; Palma, Nuno; Whyment, Andrew; Spanswick, David; Soares-da-Silva, Patrício
Journal:
Neuropharmacology
Issue:
Volume 89(2015)
Page Start:
122
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Testing the nonclinical Comprehensive In Vitro Proarrhythmia Assay (CiPA) paradigm with an established anti‐seizure medication: Levetiracetam case study. Issue 1 (7th February 2023)

Authors:
Delaunois, Annie; Mathy, François‐Xavier; Cornet, Miranda; Gryshkova, Vitalina; Korlowski, Chloé; Bonfitto, François; Koch, Juliane; Schlit, Anne‐Françoise; Hebeisen, Simon; Passini, Elisa; Rodriguez, Blanca; Valentin, Jean‐Pierre
Journal:
Pharmacology research & perspectives
Issue:
Volume 11:Issue 1(2023)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗